A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...

A landmark study led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, ...

A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical ...

A landmark Phase I/II clinical study led by researchers at Skåne University Hospital and Lund University has shown that transplanting stem-cell-derived dopamine progenitor cells into the brain is ...

Stem cell-derived dopamine cell transplantation appears to be a feasible approach to replacing dopamine-producing neurons lost in Parkinson’s disease (PD), although its long-term clinical benefit and ...